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Abstract The kinetics of spontaneous and human glutathione transferase catalysed formation of S-nitrosoglutathione(GSNO) from glutathi- 
one(GSH) and n-butyl- or amyl nitrite have been studied. At physiological pH and temperature, k2values of 22.3 and 21.0 M -~ "min -~ were obtained 
for n-butyl- and amyl nitrites, respectively. Rate enhancements, (kcJKm × k2) x 10 -4, due to purified human GSH transferases A 1-1, A2-2 and M 1 a- 1 a 
were, respectively, 7.00, 2.94 and 10.6 for n-butyl nitrite and 121, 3.92 and 34.5 for amyl nitrite. GSH transferase PI-1 showed no detectable catalysis 
of the formation of GSNO. The data suggest hat the presence of GSTs AI-1, A2-2 or MI-1 contribute substantially to intracellular metabolism 
of alkyl nitrites to GSNO. The results may be significant with regard to the immunotoxicity of alkyl nitrites. 
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1. Introduction 
In recent years amyl and n-butyl nitrite have been commonly 
used as recreational drugs by homosexuals [1]. Such alkyl ni- 
trites react readily with thiols to form S-nitrosothiols [2,3]. 
S-Nitrosothiols display many biological effects (smooth muscle 
relaxation, vasodilation, platelet deactivation and NMDA-as-  
sociated neurotransmission) which are commonly associated 
with nitric oxide [4-7]. Like nitric oxide, S-nitrosothiols may 
also cause cytotoxicity e.g. in hepatocytes [8] and cytostasis in 
activated T-lymphocytes [9]. Toxic effects are thought o be due 
to S-nitrosation of important protein thiols (e.g. in the active 
site of glyceraldehyde-3-phosphate dehydrogenase) or the for- 
mation of nitric oxide complexes of mitochondrial iron-sulphur 
respiratory enzymes. 
The toxicity of n-butyl nitrite to rat hepatocytes was shown 
to be mediated by GSNO, and its formation was catalysed by 
the cytosolic fraction [8]. Such a reaction is likely to be a novel 
property of GSH transferases(EC. 2.5.1.18). Hence, we have 
examined the activity of the major human GSH transferase 
homodimers (AI-1,  A2-2, MI -1  and PI -1 [10]) towards amyl- 
and n-butyl nitrite. 
2. Materials and methods 
Human GSH transferases were purified from liver (GSTs AI 1, 
A2-2 and Mla- la) or kidney (GSTPI-1) soluble fractions by affinity 
chromatography on GSH-agarose followed by hydroxy-apatite chrom- 
atography and anion-exchange FPLC [11]. Aliquots were snap-frozen 
and stored at -20oC. Upon thawing, the amount of active enzyme was 
determined according to its activity towards l-chloro-2,4-dinitroben- 
zene [12]. 
The formation of GSNO from GSH and alkyl nitrites was quanti- 
tated from the increase in A334 (e: 870 M -1 -cm-t). Assays were carried 
out at 37°C in 50 mM KCI, 40 mM sodium phosphate, pH 7.40 contain- 
ing 10/.tM bathocuproine disulphonate as copper chelator to stabilize 
the nitrosothiol [13]. Stock solutions (60 mM) ofamyl- and butyl nitrite 
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tathione. 
were prepared in acetone and added to assay buffer containing 1.5 mM 
GSH in the range from 24).02 mM. After determination f the sponta- 
neous rate of GSNO formation, GST was added and the catalytic rate, 
if any, measured. Assays were duplicated. Values of Km and Vm were 
determined by plotting sly vs. s. Statistical analysis, obtained by fitting 
v, s pairs to a rectangular hyperbola, gave standard errors from 6 to 13%. 
To determine if GSTPI-I was inhibited by amyl- or butyl nitrites (or 
GSNO), assays of activity towards 1-chloro-2,4-dinitrobenzene were 
carried out [12] in the presence or absence of 1 mM alkyl nitrite. 
To determine if GSTPI-1 catalysed the decomposition f GSNO, the 
enzyme was incubated with 1 mM synthetic GSNO [13] in assay buffer 
and monitored at 334 nm. 
3. Results 
At physiological pH and temperature we obtained values for 
k2 of 21.0 and 22.3 M -~ -min -I for the reaction of amyl- and 
n-butyl nitrite respectively with GSH. These values approxi- 
mate those expected from data obtained at 25°C [2]. The reac- 
tions were stimulated by addition of purified GSH transferases 
A I - I ,  A2-2 or M la - la  (see Table 1). The greatest Fm~x and rate 
enhancement were seen with GST A I -1  and amyl nitrite. With 
n-butyl nitrite, however, GSTMla - la  was most effective. 
GSTA2-2 was less efficient but displayed the lowest/i'm values. 
GSTP I - I  showed no detectable catalysis of GSNO forma- 
tion in the presence of alkyl nitrite and GSH (< 0.1% of that 
of the other GSTs). This was not due to inhibition of the 
enzyme (e.g. by nitrosation) or binding of GSNO, since activity 
towards l-chloro-2,4-dinitrobenzene was unaffected. Further- 
more, GSTPI -1  did not stimulate the decomposition of GSNO. 
4. Discussion 
The reaction of alkyl nitrites with thiols to produce S-nitro- 
sothiols is well known [1], and catalysis by GSH transferases 
of the reaction with GSH is to be expected. The data presented 
suggest hat the catalysis of GSNO formation from n-butyl 
nitrite in rat hepatocyte cytosol, as seen by Meloche and 
O'Brien [8] was due to GSH transferases. 
While the catalysis of GSNO formation by GSH transferases 
A I -1 ,  A2-2 and MI -1  was expected, the failure o fGSH trans- 
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Table 1 
Kinetic data for spontaneous and GST-catalysed formation of GSNO from GSH and amyl- or butyl nitrite 
GST Km Vm Kcat/Kmlk2* 
(mM) (flmol/min/mg) (X 10 -4) 
amyl- butyl- amyl- butyl- amyl- butyl- 
AI-I  1.40 1.34 1370 83.8 116 7.0 
A2 2 0.39 0.23 12.3 6.1 3.7 3.0 
Mla- la 1.78 1.58 494 149 33.0 10.6 
*Values for k2 were 21.0 and 22.3 M-~.min -t for amyl- and butyl nitrite, respectively. 
ferase PI-1 to carry out this reaction is curious and, so far, 
unexplained. GSNO has been shown to inhibit rat GSH trans- 
ferase activity [14] but this was not the cause of lack of GSTP 1- 
1 activity in GSNO synthesis. Furthermore, GSTPI-1 cataly- 
sed neither the decomposition of GSNO, nor the formation of 
S-alkyl glutathione from alkyl nitrite (data not shown). 
The inhibition of T-lymphocyte proliferation by GSNO was 
studied by adding 10/IM GSNO to the medium [9]. Since no 
mechanism for uptake of GSNO has been described, it remains 
unclear whether GSNO acted at the cell surface or intracellu- 
larly. Amyl- and butyl nitrites, on the other hand, are likely to 
enter cells by free diffusion, and lead to rapid intracellular 
GSNO formation as seen with rat hepatocytes in vitro [8]. 
Extracellular S-nitrosothiol formation is likely to be limited due 
to the low concentration of low molecular weight thiols in 
extracellular fluid [15]. Using the data in Table 1, the contribu- 
tion of GSH transferases to intracellular GSNO formation may 
be estimated. Table 2 shows the estimated initial rates of forma- 
tion of GSNO, spontaneous and GSH transferase-catalysed, in 
a 'typical' human hepatocyte containing 1 mg/ml G STA 1 - 1 [ 16] 
or a peripheral blood mononuclear leucocyte containing 0.1 
mg/ml GSTMI-1  [17] assuming that each contains 5mM GSH 
and the concentration of alkyl nitrite achieved is 10/IM. The 
analysis hows that GSH transferase catalysis is of far greater 
significance than the spontaneous reaction. The estimated rate 
of hepatocyte GSNO synthesis from 10/IM alkyl nitrite is so 
high that most of the reaction would occur in seconds (less than 
1 s for amyl nitrite). Therefore, amounts of these alkyl nitrites 
passing the liver unaltered should be very low. Nevertheless 
considerable xtrahepatic GSNO synthesis is to be expected 
following inhalation of alkyl nitrite in tissues and blood cells. 
The bulk of the leucocyte GSNO synthesis hould occur in 
approximately 10 s. 
GSTM 1-1 is expressed in peripheral blood mononuclear leu- 
cocytes [17], but has a null allele which, when homozygous (as 
in about 50% of the population), gives a null phenotype [18]. 
If GSTM 1 is expressed in T-lymphocytes, they might be 
Table 2 
Estimates of rates of spontaneous and GST-catalysed formation of 
GSNO in hepatocytes and peripheral blood mononuclear leucocyte 
Alkyl nitrite Initial rate of GSNO synthesis (/.tM/s) 
Spontaneous Hepatocyte a Lymphocyte b 
Amyl nitrite 
10/IM 0.018 166 (9194) c 4.6 (256) 
Butyl nitrite 
10/.tM 0.019 10 (542) 1.6 (84) 
aCalculated using data from Table 1 and assuming 5 mM GSH and 1.0 
mg/ml GST AI-1 [16]. 
bCalculated using data from Table 1 and assuming 5 mM GSH and 0.1 
mg/ml GST M1 1 [17]. 
°Fold increase over spontaneous rate in parenthesis. 
sensitive to effects of alkyl nitrites than T-lymphocytes which 
are GSTM 1 null, and could perhaps affect the development of
AIDS. However, much may depend on the cellular distribution 
of the alpha class GSTs, and the activity of other minor GSTs 
(M2-2, M3-3), not yet studied in this regard, which might offset 
a lack of GSTMI-1.  
Since prior GSH depletion protected hepatocytes from butyl 
nitrite toxicity [8], it seems possible that repeated administra- 
tion of these drugs might select for GSH-depleted populations 
of cells which are particularly sensitive to GSNO. Perhaps uch 
an effect contributes to the increased population of GSH-de- 
pleted T-cells observed in AIDS [19]. 
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